LifeStance Health Group, Inc. (LFST) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LFST Revenue Growth
LFST Revenue Analysis (2019–2025)
As of May 8, 2026, LifeStance Health Group, Inc. (LFST) generated trailing twelve-month (TTM) revenue of $1.49 billion, reflecting exceptional growth of +21.2% year-over-year. The most recent quarter (Q1 2026) recorded $403.5 million in revenue, up 5.6% sequentially.
Looking at the longer-term picture, LFST's 5-year compound annual growth rate (CAGR) stands at +30.4%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $1.42 billion in 2025, representing a new all-time high.
When compared to Healthcare sector peers including ACHC (+6.8% YoY), UHS (+10.4% YoY), and SGRY (+5.4% YoY), LFST has outperformed the peer group in terms of revenue growth. Compare LFST vs ACHC →
LFST Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LFSTCurrent | $1.5B | +21.2% | +30.4% | 1.8% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% | |
 SGRY | $3.3B | +5.4% | +12.2% | 11.8% | |
 OPCH | $5.6B | +9.3% | +13.3% | 6.0% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% |
LFST Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.42B | +13.9% | $406.3M | 28.5% | $25.7M | 1.8% |
| 2024 | $1.25B | +18.5% | $402.4M | 32.2% | $-31,613,000 | -2.5% |
| 2023 | $1.06B | +22.8% | $302.1M | 28.6% | $-189,134,000 | -17.9% |
| 2022 | $859.5M | +28.8% | $237.0M | 27.6% | $-210,174,000 | -24.5% |
| 2021 | $667.5M | +77.0% | $201.5M | 30.2% | $-286,353,000 | -42.9% |
| 2020 | $377.2M | +77.5% | $134.3M | 35.6% | $15.4M | 4.1% |
| 2019 | $212.5M | - | $62.4M | 29.4% | $15.2M | 7.2% |
See LFST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFST — Frequently Asked Questions
Quick answers to the most common questions about buying LFST stock.
Is LFST's revenue growth accelerating or slowing?
LFST revenue is accelerating at +21.2% year-over-year, exceeding the 5-year CAGR of +30.4%. TTM revenue reached $1.5B. Growth momentum has increased versus prior periods.
What is LFST's long-term revenue growth rate?
LifeStance Health Group, Inc.'s 5-year revenue CAGR of +30.4% reflects the sustained expansion pattern. Current YoY growth of +21.2% is above this long-term average.
How is LFST's revenue distributed by segment?
LFST reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.